BTLA antibody (AA 31-157)

Catalog No. ABIN5013220

This anti-BTLA antibody is a Rabbit Polyclonal antibody detecting BTLA in WB, IHC, IP and ICC. Suitable for Human.

Quick Overview for BTLA antibody (AA 31-157) (ABIN5013220)

Target: BTLA (B and T Lymphocyte Associated (BTLA))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BTLA antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Product Details anti-BTLA Antibody

Binding Specificity: AA 31-157

Purpose: Polyclonal Antibody to B And T-Lymphocyte Attenuator (BTLA)

Specificity: The antibody is a rabbit polyclonal antibody raised against BTLA. It has been selected for its ability to recognize BTLA in immunohistochemical staining and western blotting.

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: BTLA (Lys31-Arg157)

Isotype: IgG

Application Details

Application Notes: Western blotting: 0.2-2 μg/mL,1:250-2500 Immunohistochemistry: 5-20 μg/mL,1:25-100 Immunocytochemistry: 5-20 μg/mL,1:25-100 Optimal working dilutions must be determined by end user.

Comment:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 500 μg/mL

Buffer: PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

Preservative: Dithiothreitol (DTT), ProClin

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Target Details for BTLA

Target: BTLA (B and T Lymphocyte Associated (BTLA))

Alternative Name: BTLA

Background: CD272, BTLA1, B-and T-lymphocyte-associated protein

Pathways: Cancer Immune Checkpoints